Davide D’Angelo is currently a PhD student at the University of Parma. He completes his bachelor degree in 2017 in biotechnology at the University of Perugia, Italy, with a thesis on the methylation level of A.thaliana. In 2017 he moved to Parma, to complete his studies with a master's degree in Medical, Veterinary and Pharmaceutical Biotechnologies at the University of Parma, graduating with honours in 2019 with a thesis on the formulation of a pulmonary dry powder containing a vaccine against HPV. From 2019 he starts his PhD in the “Biopharmaceutics-Pharmacokinetics” program in the laboratory of pharmaceutical technology of Food and Drug Department at the University of Parma, working under the supervision of Professors Francesca Buttini and Fabio Sonvico on a project entitled “Particle engineering applied for the development of dry powders for inhalation containing biotechnological drugs”. His research is actually focused on the development of an inhalable powder containing cyclosporine for the prevention of pulmonary rejection after transplantation and potentially for the containment of the "cytokine storm" caused by Sars-CoV-2 infection.
